ClariVest Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

ClariVest Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-192,398	Closed	-$210K	–	926
2023 Q3	$210K	Sell	192,398 -318,976	-62%	-$560K	0.01%	370
2023 Q2	$1.17M	Buy	511,374 +121,213	+31%	+$322K	0.06%	214
2023 Q1	$949K	Buy	390,161 +401	+0.1%	+$919	0.04%	289
2022 Q4	$744K	Sell	389,760 -3,031	-0.8%	-$6.45K	0.04%	323
2022 Q3	$943K	Buy	+392,791	New	+$1.09M	0.05%	265

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClariVest Asset Management's LXRX Position: Q4 2023 in Review

ClariVest Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2023, closing a stake of 192,398 shares — an estimated $210K sold.

ClariVest Asset Management first reported a position in LXRX in Q3 2022 and held it in 5 quarters. The position peaked at $1.17M in Q2 2023. 106 funds tracked by Wall St. Rank hold LXRX as of Q4 2023.

ClariVest Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
ClariVest Asset Management sold 192,398 Lexicon Pharmaceuticals shares in Q4 2023, an estimated $210K.
ClariVest Asset Management first reported a position in Lexicon Pharmaceuticals in Q3 2022 and held it in 5 quarters.
ClariVest Asset Management's Lexicon Pharmaceuticals position peaked at $1.17M in Q2 2023.
106 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2023.

Based on ClariVest Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.